Point: The relationship between postimplant dose metrics and biochemical no evidence of disease following low dose rate prostate brachytherapy: Is there an elephant in the room?-Reference-Cited by-同舟云学术

Point: The relationship between postimplant dose metrics and biochemical no evidence of disease following low dose rate prostate brachytherapy: Is there an elephant in the room?

Published:2010-10 Issue:4 Volume:9 Page:289-292
ISSN:1538-4721
Container-title:Brachytherapy
language:en
Short-container-title:Brachytherapy

Author:

Morris W. James,Halperin Ross,Spadinger Ingrid

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology

Reference18 articles.

1. Intraobserver and interobserver variability of MR imaging- and CT-derived prostate volumes after transperineal interstitial permanent prostate brachytherapy;Dubois;Radiology,1998

2. Interobserver variability leads to significant differences in quantifiers of prostate implant adequacy;Lee;Int J Radiat Oncol Biol Phys,2002

3. Interobserver variation in postimplant computed tomography contouring affects quality assessment of prostate brachytherapy;Crook;Brachytherapy,2002

4. Impact of prostate volume evaluation by different observers on CT-based post-implant dosimetry;Al-Qaisieh;Radiother Oncol,2002

5. Multi-institutional analysis of long-term outcomes for stages T1-T2 prostate cancer treated with permanent seed implantation;Zelefsky;Int J Radiat Oncol Biol Phys,2007

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer;International Journal of Radiation Oncology*Biology*Physics;2017-06

2. Focal therapy for prostate cancer: the technical challenges;Journal of Contemporary Brachytherapy;2017

3. Long-term results of permanent implant prostate cancer brachytherapy: A single-institution study of 675 patients treated between 1999 and 2003;Cancer/Radiothérapie;2016-06

4. Which patients benefit from post-implant CT dosimetry after real-time intraoperative planning for LDR prostate brachytherapy: Should intraoperatively planned patients be treated differently?;Journal of Medical Imaging and Radiation Oncology;2016-04

5. Regional dose metrics as predictors of biochemical failure and local recurrence after low-dose-rate prostate brachytherapy;Brachytherapy;2015-05